Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 18

1.

Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography.

Grierson JR, Schwartz JL, Muzi M, Jordan R, Krohn KA.

Nucl Med Biol. 2004 Oct;31(7):829-37.

PMID:
15464384
2.

Fully automated synthesis system of 3'-deoxy-3'-[18F]fluorothymidine.

Oh SJ, Mosdzianowski C, Chi DY, Kim JY, Kang SH, Ryu JS, Yeo JS, Moon DH.

Nucl Med Biol. 2004 Aug;31(6):803-9.

PMID:
15246372
3.

Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.

van Waarde A, Cobben DC, Suurmeijer AJ, Maas B, Vaalburg W, de Vries EF, Jager PL, Hoekstra HJ, Elsinga PH.

J Nucl Med. 2004 Apr;45(4):695-700.

4.

PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study.

Smyczek-Gargya B, Fersis N, Dittmann H, Vogel U, Reischl G, Machulla HJ, Wallwiener D, Bares R, Dohmen BM.

Eur J Nucl Med Mol Imaging. 2004 May;31(5):720-4. Epub 2004 Feb 19.

PMID:
14991243
5.

3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?

Cobben DC, Jager PL, Elsinga PH, Maas B, Suurmeijer AJ, Hoekstra HJ.

J Nucl Med. 2003 Dec;44(12):1927-32.

6.

18F-Fluorothymidine radiation dosimetry in human PET imaging studies.

Vesselle H, Grierson J, Peterson LM, Muzi M, Mankoff DA, Krohn KA.

J Nucl Med. 2003 Sep;44(9):1482-8.

7.

Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.

Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G, Mattfeldt T, Neumaier B, Reske SN, Hetzel M.

J Nucl Med. 2003 Sep;44(9):1426-31.

8.

[18F]FLT PET for diagnosis and staging of thoracic tumours.

Dittmann H, Dohmen BM, Paulsen F, Eichhorn K, Eschmann SM, Horger M, Wehrmann M, Machulla HJ, Bares R.

Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1407-12. Epub 2003 Jul 26.

PMID:
12898201
9.

3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.

Barthel H, Cleij MC, Collingridge DR, Hutchinson OC, Osman S, He Q, Luthra SK, Brady F, Price PM, Aboagye EO.

Cancer Res. 2003 Jul 1;63(13):3791-8.

10.

3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease.

Wagner M, Seitz U, Buck A, Neumaier B, Schultheiss S, Bangerter M, Bommer M, Leithäuser F, Wawra E, Munzert G, Reske SN.

Cancer Res. 2003 May 15;63(10):2681-7.

11.
12.

Early changes in [18F]FLT uptake after chemotherapy: an experimental study.

Dittmann H, Dohmen BM, Kehlbach R, Bartusek G, Pritzkow M, Sarbia M, Bares R.

Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1462-9. Epub 2002 Sep 6.

PMID:
12397465
13.

Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell lines.

Seitz U, Wagner M, Neumaier B, Wawra E, Glatting G, Leder G, Schmid RM, Reske SN.

Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1174-81. Epub 2002 Jun 4.

PMID:
12192562
14.
15.

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, Obradovich JE, Muzik O, Mangner TJ.

Nat Med. 1998 Nov;4(11):1334-6.

PMID:
9809561
16.

Regulation of human thymidine kinase during the cell cycle.

Sherley JL, Kelly TJ.

J Biol Chem. 1988 Jun 15;263(17):8350-8.

17.
18.

Supplemental Content

Support Center